Lenvatinib plus Pembrolizumab as first-line treatment in patients with advanced renal cell carcinoma – real world data from a retrospective multi-center analysis
European Urology Open Science(2023)
关键词
advanced renal cell carcinoma,renal cell carcinoma,pembrolizumab,lenvatinib,first-line,multi-center
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要